La bourse ferme dans 1 h 58 min

Bayer Aktiengesellschaft (BAYRY)

OTC Markets OTCPK - OTC Markets OTCPK Prix différé. Devise en USD
Ajouter à la liste dynamique
7,11+0,13 (+1,86 %)
À partir de 03:59PM EDT. Marché ouvert.

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Secteur(s)Healthcare
Secteur d’activitéDrug Manufacturers - General
Employés à temps plein98 189

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. William N. AndersonChairman of the Management Board & CEO9,01MS.O.1966
Mr. Wolfgang U. NicklCFO & Member of Management Board2,12MS.O.1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management2,08MS.O.1968
Mr. Rodrigo SantosMember of Management Board & President of the Crop Science Division2,31MS.O.1973
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board1,42MS.O.1964
Mr. Julio TrianaMember of Management Board & President of Consumer Health DivisionS.O.S.O.1966
Dr. Sebastian Guth Ph.D.Chief Operating OfficerS.O.S.O.S.O.
Dr. Jost ReinhardHead of Investor RelationsS.O.S.O.1972
Mr. Michael PreussHead of Communications, Government Relations and Corporate BrandS.O.S.O.S.O.
Mr. Bernd-Peter BierHead of Group FinanceS.O.S.O.1967
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Bayer Aktiengesellschaft en date du 1 juin 2024 est 3. Les scores principaux sont Audit : 10; Société : 3; Droits des actionnaires : 1; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.